Although CD44 has widely utilized as a cancer stem cell marker in several cancers including prostate cancer, the functional role of CD44 beyond cancer stem cell marker has not been heavily studied in NEPC except a recent study reporting that CD44 plays a role in glucose metabolism in NEPC [146,147]. This evidence concerns the gene CD44 and prostate carcinoma.